Researched applications In the published preclinical and clinical literature the effects of AOD-9604 are documented in the following areas: Obesity , Phase 2b failure (2007), but a complementary mechanism in combination protocols Lipolysis in animal models , robustly demonstrated (Heffernan 2001, Ng 2009) Inhibition of lipogenesis , demonstrated in hepatocytes and adipocytes Osteoarthritis and cartilage regeneration , emerging Phase 1/2 data (mLuna Pharmaceuticals 2018+) Tendinopathy , preclinical models Age-related sarcopenia (cachexia) , exploratory plans Lipodystrophy , preclinical data in animal models Hyperlipidemia , secondary endpoints in Phase 2 trials Science & studies 4.1 Key publications Heffernan M., Summers R.J., Thorburn A., et al
BPC 157 Peptide Face Cream, BPC 157 Essence, Hydrating, for All Skin Types (2 Jars) Welcome to Our Store
Most prominently, the substantial reduction in total and visceral adiposity is tightly linked to improved insulin sensitivitya core pathophysiological determinant of MASLD
Below, well explore what these peptides are, how they work, and the potential benefits they offer
Methylene Blue may help with that, too
